Skip to main content
BMC Medical Co., Ltd. logo

BMC Medical Co., Ltd. — Investor Relations & Filings

Ticker · 301367 ISIN · CNE100005WQ4 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 519 across all filing types
Latest filing 2026-05-20 Notice of Dividend Amou…
Country CN China
Listing Shenzhen Stock Exchange 301367

About BMC Medical Co., Ltd.

https://www.bmc-medical.com

BMC Medical Co., Ltd. specializes in the development and distribution of diagnostic and therapeutic solutions for sleep-disordered breathing and chronic respiratory conditions. The company’s core product portfolio includes continuous positive airway pressure (CPAP) devices, bilevel positive airway pressure (BPAP) systems, and high-flow oxygen therapy equipment. These are complemented by a range of patient interfaces, including nasal, pillow, and full-face masks. BMC integrates digital health capabilities through cloud-based management platforms, enabling remote data analysis and patient monitoring. By focusing on technical innovation and clinical efficacy, the company provides integrated respiratory care systems designed to improve patient compliance and therapeutic outcomes for conditions such as obstructive sleep apnea and chronic obstructive pulmonary disease.

Recent filings

Filing Released Lang Actions
2025年年度权益分派实施公告
Notice of Dividend Amount Classification · 90% confidence The document is a formal announcement detailing the implementation of the company’s 2025 profit distribution (cash dividend per share, capital reserve transfer ratio), record date, ex-dividend date, payment methods, and related share capital adjustments. It is clearly a dividend distribution notice, matching the “Notice of Dividend Amount” category.
2026-05-20 Chinese
回购报告书
Transaction in Own Shares Classification · 95% confidence The document is a detailed “回购报告书” (share repurchase report) by Beijing Ruimait Medical Technology Co., Ltd., describing the company’s buyback plan: use of oversubscription funds, repurchase price range, total amount, share quantities and proportions, purposes (employee share incentive), funding source, implementation period, authorization, risk disclosures, and procedural details. This is a classic share buyback scheme disclosure, fitting the “Transaction in Own Shares” category.
2026-05-19 Chinese
北京国枫律师事务所关于北京瑞迈特医疗科技股份有限公司2025年年度股东会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 91% confidence The document is a legal opinion letter (“法律意见书”) prepared by a law firm regarding the convening, procedures, and voting results of the company's 2025 Annual General Meeting. It contains detailed vote counts for each resolution, fitting the definition of Declaration of Voting Results & Voting Rights Announcements, which covers the official results from shareholder votes at a general meeting. Hence it classifies as DVA.
2026-05-15 Chinese
中国国际金融股份有限公司关于北京瑞迈特医疗科技股份有限公司2025年度持续督导培训情况的报告
Regulatory Filings Classification · 75% confidence The document is a formal compliance report submitted by the sponsor (中金公司) to the Shenzhen Stock Exchange detailing the 2025 continuous supervision training conducted for the issuer’s controlling shareholders, actual controller, directors and senior management. It is not a financial report, not an earnings release, and not a presentation – it is a regulatory compliance filing that does not fit into any other specific category. Therefore it defaults to Regulatory Filings (RNS).
2026-05-13 Chinese
关于回购股份事项前十大股东和前十大无限售条件股东持股情况的公告
Transaction in Own Shares Classification · 90% confidence The document is an official announcement by Beijing Ruimaite Medical Technology Co., Ltd. disclosing the top ten shareholders and top ten unrestricted shareholders registered as of the record date ahead of a share repurchase plan. It references share buyback rules and provides detailed shareholding tables. This is not a financial report (e.g., annual/interim), nor a dividend or capital raising notice, but a transaction in own shares (share repurchase) disclosure. According to the classification schema, this falls under Transaction in Own Shares (Code: POS).
2026-05-12 Chinese
关于公司特定股东、持股5%以上股东及其一致行动人减持计划届满实施情况的公告
Major Shareholding Notification Classification · 85% confidence The document is an official announcement detailing the implementation and final results of share reduction plans by specific shareholders and holders of more than 5% of the company’s shares. It provides tables of pre- and post-reduction shareholdings, share counts, and percentages, in compliance with securities laws and exchange guidelines. This falls under notifications of changes in significant share ownership levels by major shareholders. Therefore, it should be classified as a Major Shareholding Notification.
2026-05-11 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.